Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy

Modeling challenges of hepatitis D virus kinetics during bulevirtide-based therapy

Saved in:

Bibliographic Details
Main Authors:	Adquate Mhlanga, Ori Wasserman, Pietro Lampertico, Scott J. Cotler, Harel Dahari
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	JHEP Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555924002155
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Current and future therapeutic options for chronic hepatitis D virus infection
by: Mariantonietta Pisaturo, et al.
Published: (2025-02-01)

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
by: Jona T. Stahmeyer, et al.
Published: (2013-12-01)

Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
by: Elena Franchi, et al.
Published: (2023-12-01)

Issues occult hepatitis B virus infection
by: I. A. Morozov, et al.
Published: (2012-07-01)

A Review on Perception of Binding Kinetics in Affinity Biosensors: Challenges and Opportunities
by: Benjamin McCann, et al.
Published: (2025-01-01)

Challenges faced during antitubercular therapy
by: B. K. Likhitha, et al.
Published: (2024-07-01)

Comparison of 2-D and 3-D Analysis of Running Kinematics and Actual Versus Predicted Running Kinetics
by: Caitlyn Martinez, et al.
Published: (2022-06-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
by: Núria Granel, et al.
Published: (2025-02-01)

Uptake and Release Kinetics Longevity in Stimuli-Responsive Hydrogels for Hydrophilic Drug Therapy
by: Parker M. Toews, et al.
Published: (2025-01-01)

Co-dynamics of hepatitis B and C viruses under the influence of CTL immunity
by: A.M. Elaiw, et al.
Published: (2025-04-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Knowledge and awareness of perinatal antiviral use in the prevention of mother-to-child hepatitis B virus transmission among maternal chronic hepatitis carriers
by: Jia Ming Low, et al.
Published: (2024-09-01)

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
by: Andrew Trigg, et al.
Published: (2019-02-01)

Global progress, challenges and strategies in eliminating public threat of viral hepatitis
by: Sihui Zhang, et al.
Published: (2025-02-01)

Physical Kinetics: course of theoretical physics volume 10 /
by: Lifshit︠s︡, E. M.
Published: (1981)

Virus-inspired biogenic delivery system for advancing cancer therapy
by: Di Sun, et al.
Published: (2025-03-01)

Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01)

Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries
by: Sten H Vermund, et al.
Published: (2025-01-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Cognitive therapy for challenging problems : what to do when the basics don't work /
by: Beck, Judith S.
Published: (2005)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)

Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
by: M. V. Sokolova, et al.
Published: (2018-08-01)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
by: Raymond Odhiambo, et al.
Published: (2013-06-01)

Seroprevalence of hepatitis B and C virus among a group of hemophilia patients in Kurdistan Region, Iraq
by: Salih A. Hama
Published: (2025-02-01)

Pepper Mild Mottle Virus
by: Scott Adkins, et al.
Published: (2018-07-01)

Pepper Mild Mottle Virus
by: Scott Adkins, et al.
Published: (2018-07-01)

Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge
by: Chang Won Ha, et al.
Published: (2025-01-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

Two ways to one goal: new strategy of antiviral therapy for chronic hepatitis C
by: S. N. Batskikh
Published: (2012-11-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs
by: Ye. N. German, et al.
Published: (2011-03-01)

Recommendations for the use of antiretroviral therapy in adults living with human immunodeficiency virus in Singapore
by: Chiaw Yee Choy, et al.
Published: (2024-05-01)

Relating quantum mechanics and kinetics of neutrino oscillations
by: A. Kartavtsev
Published: (2020-01-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Long-term results of antiviral therapy in patients with chronic hepatitis C with sustained virologic response
by: T. M. Ignatova, et al.
Published: (2013-09-01)